Trial Details
RecruitingBasic Information
| Clinical ID | c5662 |
|---|---|
| Identifier | NL-OMON51420 |
| Trial Title | Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel disease: a randomized controlled pilot study - SILVER-study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's disease and ulcerative colitis inflammatory bowel diseases;10017969 |
| Interventions | Based on concentration measurements, the injection interval will be adjusted to every 2, 3 or 4 weeks. During screening, a serum concentration measurement will be performed in all patients, followed by a finger prick in patients in the inte |
Participant Information
| Sponsor | Amsterdam UMC |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |